Growth Metrics

Healthequity (HQY) Depreciation & Amortization (CF) (2016 - 2026)

Healthequity has reported Depreciation & Amortization (CF) over the past 14 years, most recently at $38.7 million for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) fell 1.28% year-over-year to $38.7 million; the TTM value through Jan 2026 reached $154.7 million, down 4.8%, while the annual FY2026 figure was $154.7 million, 4.8% down from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 was $38.7 million at Healthequity, roughly flat from $38.8 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $43.6 million in Q3 2024 and troughed at $37.8 million in Q4 2023.
  • A 5-year average of $39.4 million and a median of $38.9 million in 2024 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): rose 27.63% in 2022 and later fell 11.82% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $40.5 million in 2022, then decreased by 6.72% to $37.8 million in 2023, then grew by 7.78% to $40.7 million in 2024, then dropped by 4.77% to $38.8 million in 2025, then decreased by 0.25% to $38.7 million in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for HQY at $38.7 million in Q1 2026, $38.8 million in Q4 2025, and $38.5 million in Q3 2025.